Trademark: 85296570
Status Date
Friday, September 9, 2022
Registration Number
4106856
Registration Date
Tuesday, February 28, 2012
Filing Date
Friday, April 15, 2011
Published for Opposition
Tuesday, September 13, 2011
Cancellation Date
Friday, September 9, 2022
5 a pharmaceutical preparation of thromboxane A2 receptor antagonist compound used to treat liver and kidney conditions in hospitalized patients
Sep 9, 2022
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Feb 28, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Feb 13, 2018
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Feb 13, 2018
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Feb 13, 2018
Case Assigned To Post Registration Paralegal
Jan 29, 2018
Teas Section 8 & 15 Received
Feb 28, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 28, 2012
Registered-Principal Register
Jan 27, 2012
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 26, 2012
Law Office Registration Review Completed
Jan 26, 2012
Allowed Principal Register - Sou Accepted
Jan 17, 2012
Statement Of Use Processing Complete
Dec 14, 2011
Use Amendment Filed
Jan 17, 2012
Case Assigned To Intent To Use Paralegal
Dec 14, 2011
Teas Statement Of Use Received
Nov 8, 2011
Noa E-Mailed - Sou Required From Applicant
Sep 13, 2011
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2011
Published For Opposition
Aug 5, 2011
Law Office Publication Review Completed
Aug 5, 2011
Assigned To Lie
Jul 25, 2011
Approved For Pub - Principal Register
Jul 25, 2011
Examiner's Amendment Entered
Jul 25, 2011
Notification Of Examiners Amendment E-Mailed
Jul 25, 2011
Examiners Amendment E-Mailed
Jul 25, 2011
Examiners Amendment -Written
Jul 21, 2011
Assigned To Examiner
Apr 19, 2011
New Application Office Supplied Data Entered In Tram
Apr 19, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
